MedPath

Tobramycin

Tobramycin OphthalmicSolution USP, 0.3%

Approved
Approval ID

f54c1882-ca08-47f3-9c02-93551f39905e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 1, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

tobramycin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-204
Application NumberANDA063176
Product Classification
M
Marketing Category
C73584
G
Generic Name
tobramycin
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateFebruary 13, 2006
FDA Product Classification

INGREDIENTS (8)

tobramycinActive
Quantity: 3 mg in 1 mL
Code: VZ8RRZ51VK
Classification: ACTIB
sodium sulfateInactive
Code: 0YPR65R21J
Classification: IACT
TYLOXAPOLInactive
Code: Y27PUL9H56
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Quantity: 0.1 mg in 1 mL
Code: F5UM2KM3W7
Classification: IACT
boric acidInactive
Code: R57ZHV85D4
Classification: IACT
sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tobramycin - FDA Drug Approval Details